The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| CymaBay Therapeutics, Inc. | COMMON STOCK | 23257D103 | 17,421 | 5,905,400 | SH | SOLE | 5,905,400 | 0 | 0 | ||
| Cogent Biosciences, Inc. | COMMON STOCK | 19240Q201 | 31,399 | 3,481,042 | SH | SOLE | 3,481,042 | 0 | 0 | ||
| Chinook Therapeutics, Inc. | COMMON STOCK | 16961L106 | 13,930 | 796,460 | SH | SOLE | 796,460 | 0 | 0 | ||
| Magenta Therapeutics, Inc. | COMMON STOCK | 55910K108 | 2,549 | 2,124,122 | SH | SOLE | 2,124,122 | 0 | 0 | ||
| Zai Lab LTD-ADR | COMMON STOCK | 98887Q104 | 3,295 | 95,000 | SH | SOLE | 95,000 | 0 | 0 | ||
| Aclaris Therapeuitics, Inc. | COMMON STOCK | 00461U105 | 15,983 | 1,144,939 | SH | SOLE | 1,144,939 | 0 | 0 | ||
| Elevation Oncology, Inc. | COMMON STOCK | 28623U101 | 777 | 555,000 | SH | SOLE | 555,000 | 0 | 0 | ||
| Aerovate Therapeutics, Inc. | COMMON STOCK | 008064107 | 13,904 | 889,572 | SH | SOLE | 889,572 | 0 | 0 | ||
| Iveric Bio, Inc. | COMMON STOCK | 46583P102 | 28,035 | 2,914,250 | SH | SOLE | 2,914,250 | 0 | 0 | ||
| Viridian Therapeutics Inc | COMMON STOCK | 92790C104 | 15,203 | 1,314,000 | SH | SOLE | 1,314,000 | 0 | 0 | ||
| Tyra Biosciences, Inc. | COMMON STOCK | 90240B106 | 6,409 | 896,418 | SH | SOLE | 896,418 | 0 | 0 | ||
| Alpine Immune Sciences, Inc. | COMMON STOCK | 02083G100 | 4,921 | 578,260 | SH | SOLE | 578,260 | 0 | 0 | ||
| Akouos, Inc. | COMMON STOCK | 00973J101 | 6,332 | 1,350,006 | SH | SOLE | 1,350,006 | 0 | 0 | ||
| Merus N.V. | COMMON STOCK | N5749R100 | 6,792 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
| Entrada Therapeutics, Inc. | COMMON STOCK | 29384C108 | 8,084 | 663,694 | SH | SOLE | 663,694 | 0 | 0 | ||
| Pardes Biosciences, Inc. | COMMON STOCK | 69945Q105 | 181 | 59,039 | SH | SOLE | 59,039 | 0 | 0 | ||
| Kura Oncology, Inc. | COMMON STOCK | 50127T109 | 21,403 | 1,167,642 | SH | SOLE | 1,167,642 | 0 | 0 | ||
| AnaptysBio, Inc. | COMMON STOCK | 032724106 | 1,188 | 58,515 | SH | SOLE | 58,515 | 0 | 0 | ||
| Tango Therapeutics, Inc. | COMMON STOCK | 87583X109 | 5,310 | 1,172,250 | SH | SOLE | 1,172,250 | 0 | 0 | ||
| Geron Corporation | COMMON STOCK | 374163103 | 23,399 | 15,096,342 | SH | SOLE | 15,096,342 | 0 | 0 | ||
| MoonLake Immunotherapeutics | COMMON STOCK | 61559X104 | 5,250 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
| 89bio, Inc. | COMMON STOCK | 282559103 | 3,649 | 1,133,196 | SH | SOLE | 1,133,196 | 0 | 0 | ||